Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
FRANKLIN RESOURCES INC
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 2,262,479 | -12,012 | 57,263,344,000 | -15,998,013,000 | $25,310.00 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 2,274,491 | -111,527 | 73,261,357,000 | 73,196,935,000 | $32,210.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 2,386,018 | 19,651 | 64,422,000 | 31,719,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 2,366,367 | 153,320 | 32,703,000 | -10,451,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 2,213,047 | 392,978 | 43,154,000 | 13,450,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 1,820,069 | -1,610 | 29,704,000 | -21,047,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 1,821,679 | -4,088 | 50,751,000 | -3,365,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 1,825,767 | 69,157 | 54,116,000 | 5,018,000 | $29.64 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 1,756,610 | 747 | 49,098,000 | -664,000 | $27.95 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 1,755,863 | -822,170 | 49,762,000 | -15,049,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 2,578,033 | -888,855 | 64,811,000 | -18,498,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 3,466,888 | -224,600 | 83,309,000 | 28,675,000 | $24.03 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 3,691,488 | 108,516 | 54,634,000 | -3,518,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 3,582,972 | 16,397 | 58,152,000 | 11,786,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 3,566,575 | 52,525 | 46,366,000 | 789,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 3,514,050 | 84,794 | 45,577,000 | -8,468,000 | $12.97 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 3,429,256 | 453,412 | 54,045,000 | -5,859,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 2,975,844 | 426,109 | 59,904,000 | -3,457,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 2,549,735 | -104,701 | 63,361,000 | -9,504,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 2,654,436 | -518,726 | 72,865,000 | -24,868,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 3,173,162 | -221,040 | 97,733,000 | -23,610,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 3,394,202 | 105,424 | 121,343,000 | 30,737,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 3,288,778 | -86,460 | 90,606,000 | 1,500,000 | $27.55 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 3,375,238 | 391,638 | 89,106,000 | 27,047,000 | $26.40 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 2,983,600 | -296,984 | 62,059,000 | -5,849,000 | $20.80 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 3,280,584 | 173,305 | 67,908,000 | 17,539,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 3,107,279 | 3,107,279 | 50,369,000 | 50,369,000 | $16.21 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 3,166,536 | -162,534 | 43,065,000 | -15,061,000 | $13.60 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 3,329,070 | 150,175 | 58,126,000 | -50,465,000 | $17.46 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 3,178,895 | -65,385 | 108,591,000 | 12,042,000 | $34.16 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 3,244,280 | 3,244,280 | 96,549,000 | 96,549,000 | $29.76 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 3,066,887 | -331,305 | 98,079,000 | 27,635,000 | $31.98 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 3,398,192 | 3,398,192 | 70,444,000 | 70,444,000 | $20.73 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 2,754,139 | 2,754,139 | 46,654,000 | 46,654,000 | $16.94 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 1,386,899 | 1,386,899 | 26,809,000 | 26,809,000 | $19.33 |
| << Prev Next >> |
|